355 related articles for article (PubMed ID: 16788316)
1. Efficacy of recombinant activated factor VII in unselected patients with uncontrolled haemorrhage: a single centre experience.
Payne EM; Brett SJ; Laffan MA
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):397-402. PubMed ID: 16788316
[TBL] [Abstract][Full Text] [Related]
2. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
[TBL] [Abstract][Full Text] [Related]
3. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
4. Recombinant factor VIIa: unregulated continuous use in patients with bleeding and coagulopathy does not alter mortality and outcome.
Ganguly S; Spengel K; Tilzer LL; O'neal B; Simpson SQ
Clin Lab Haematol; 2006 Oct; 28(5):309-12. PubMed ID: 16999720
[TBL] [Abstract][Full Text] [Related]
5. The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients.
Aldouri M
Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():41-6. PubMed ID: 12214147
[TBL] [Abstract][Full Text] [Related]
6. Predicting response to recombinant factor VIIa in non-haemophiliac patients with severe haemorrhage.
Bowles KM; Callaghan CJ; Taylor AL; Harris RJ; Pettigrew GJ; Baglin TP; Park GR
Br J Anaesth; 2006 Oct; 97(4):476-81. PubMed ID: 16914465
[TBL] [Abstract][Full Text] [Related]
7. The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt trauma.
Geeraedts LM; Kamphuisen PW; Kaasjager HA; Verwiel JM; van Vugt AB; Frölke JP
Injury; 2005 Apr; 36(4):495-500. PubMed ID: 15755430
[TBL] [Abstract][Full Text] [Related]
8. Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
Parameswaran R; Shapiro AD; Gill JC; Kessler CM;
Haemophilia; 2005 Mar; 11(2):100-6. PubMed ID: 15810910
[TBL] [Abstract][Full Text] [Related]
9. Analysis and results of the recombinant factor VIIa extended-use registry.
Laffan M; O'Connell NM; Perry DJ; Hodgson AJ; O'Shaughnessy D; Smith OP
Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S35-8. PubMed ID: 14567534
[TBL] [Abstract][Full Text] [Related]
10. Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery.
Hyllner M; Houltz E; Jeppsson A
Eur J Cardiothorac Surg; 2005 Aug; 28(2):254-8. PubMed ID: 15935687
[TBL] [Abstract][Full Text] [Related]
11. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
[TBL] [Abstract][Full Text] [Related]
12. Recombinant factor VIIa as last-resort treatment of desperate haemorrhage.
Palmason R; Vidarsson B; Sigvaldason K; Ingimarsson JP; Gudbjartsson T; Sigurdsson GH; Onundarson PT
Acta Anaesthesiol Scand; 2012 May; 56(5):636-44. PubMed ID: 22489992
[TBL] [Abstract][Full Text] [Related]
13. Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review.
Grounds M
Blood Rev; 2003 Sep; 17 Suppl 1():S11-21. PubMed ID: 14697209
[TBL] [Abstract][Full Text] [Related]
14. Low-dose recombinant factor VIIa for massive bleeding: a single centre observational cohort study with 73 patients.
Schmid P; Mordasini A; Luginbühl M; Regli B; Kohler HP; Zimmermann H; Inderbitzin D; Hirt A; Lämmle B; Alberio L
Swiss Med Wkly; 2011; 141():w13213. PubMed ID: 21735365
[TBL] [Abstract][Full Text] [Related]
15. A multicenter assessment of recombinant factor VIIa off-label usage: clinical experiences and associated outcomes.
MacLaren R; Weber LA; Brake H; Gardner MA; Tanzi M
Transfusion; 2005 Sep; 45(9):1434-42. PubMed ID: 16131375
[TBL] [Abstract][Full Text] [Related]
16. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
Bhaskar B; Zeigenfuss M; Choudhary J; Fraser JF
Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
[TBL] [Abstract][Full Text] [Related]
17. Recombinant activated coagulation factor VII and bleeding trauma patients.
Rizoli SB; Nascimento B; Osman F; Netto FS; Kiss A; Callum J; Brenneman FD; Tremblay L; Tien HC
J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
[TBL] [Abstract][Full Text] [Related]
18. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
[TBL] [Abstract][Full Text] [Related]
19. The use of recombinant activated factor VII for controlling life-threatening bleeding in Dengue Shock Syndrome.
Chuansumrit A; Tangnararatchakit K; Lektakul Y; Pongthanapisith V; Nimjaroenniyom N; Thanarattanakorn P; Wongchanchailert M; Komwilaisak P
Blood Coagul Fibrinolysis; 2004 Jun; 15(4):335-42. PubMed ID: 15166920
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Outcomes Using Low-Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery.
Brase J; Finger B; He J; Wirtz K; Stun L; McMillen R; Flynn B
Ann Thorac Surg; 2016 Jul; 102(1):35-40. PubMed ID: 26874365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]